Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Subcutaneous Pasireotide in Patients With Cushing's Disease: Results From an Open-Label, Multicenter, Single-Arm, Multinational, Expanded-Access Study
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-16
DOI
10.3389/fendo.2019.00436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Medical Therapy for Cushing’s Syndrome in the Twenty-first Century
- (2018) Nicholas A. Tritos et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Hepatic safety of ketoconazole in Cushing’s syndrome: results of a Compassionate Use Programme in France
- (2018) Jacques Young et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Pituitary-Directed Therapies for Cushing’s Disease
- (2018) Fabienne Langlois et al. Frontiers in Endocrinology
- Medical Therapy with Pasireotide in Recurrent Cushing’s Disease: Experience of Patients Treated for At Least 1 Year at a Single Center
- (2017) Chris G. Yedinak et al. Frontiers in Endocrinology
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: DIAGNOSIS OF RECURRENCE IN CUSHING DISEASE
- (2016) Maria Fleseriu et al. Endocrine Practice
- A Single-Center 10-Year Experience with Pasireotide in Cushing’s Disease: Patients’ Characteristics and Outcome
- (2016) L. Trementino et al. HORMONE AND METABOLIC RESEARCH
- Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
- (2016) Maria Fleseriu et al. Pituitary
- Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
- (2016) Julie M. Silverstein Pituitary
- Complications of Cushing's syndrome: state of the art
- (2016) Rosario Pivonello et al. Lancet Diabetes & Endocrinology
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
- (2015) Eleni Daniel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cushing's syndrome
- (2015) André Lacroix et al. LANCET
- Pasireotide treatment significantly improves clinical signs and symptoms in patients with Cushing's disease: results from a Phase III study
- (2014) Rosario Pivonello et al. CLINICAL ENDOCRINOLOGY
- Ketoconazole in Cushing's Disease: Is It Worth a Try?
- (2014) Frederic Castinetti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin analogs and gallstones: A retrospective survey on a large series of acromegalic patients
- (2014) R. Attanasio et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study
- (2013) Olaf M. Dekkers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
- (2013) Maria Fleseriu et al. JOURNAL OF NEURO-ONCOLOGY
- Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
- (2013) Annamaria Colao et al. Pituitary
- Quality of life in patients with Cushing's disease: a modern approach
- (2012) Annamaria Colao et al. CLINICAL ENDOCRINOLOGY
- MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
- (2012) R A Feelders et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
- (2012) Maria Fleseriu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality in Cushing's syndrome: A systematic review and meta-analysis
- (2011) D. Graversen et al. European Journal of Internal Medicine
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
- (2008) S M Webb et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin and dopamine receptors as targets for medical treatment of Cushing’s Syndrome
- (2008) C. de Bruin et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation